James J Prisciandaro1, Bryan K Tolliver1, Stacia M DeSantis2. 1. Department of Psychiatry and Behavioral Sciences,Medical University of SC,Charleston, SC,USA. 2. School of Public Health,University of Texas Health Science Center,Houston, TX,USA.
Abstract
BACKGROUND: Although bipolar disorder (BD) is a fundamentally cyclical illness, a divided model of BD that emphasizes polarity over cyclicity has dominated modern psychiatric diagnostic systems since their advent in the 1980s. However, there has been a gradual return to conceptualizations of BD which focus on longitudinal course in the research community due to emerging supportive data. Advances in longitudinal statistical methods promise to further progress the field. METHODS: The current study employed hidden Markov modeling to uncover empirically derived manic and depressive states from longitudinal data [i.e. Young Mania Rating Scale and Montgomery-Asberg Depression Rating Scale responses across five occasions from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study], estimate participants' probabilities of transitioning between these states over time (n = 3918), and evaluate whether clinical variables (e.g. rapid cycling and substance dependence) predict participants' state transitions (n = 3229). RESULTS: Analyses identified three empirically derived mood states ('euthymic,' 'depressed,' and 'mixed'). Relative to the euthymic and depressed states, the mixed state was less commonly experienced, more temporally unstable, and uniquely associated with rapid cycling, substance use, and psychosis. Individuals assigned to the mixed state at baseline were relatively less likely to be diagnosed with BD-II (v. BD-I), more likely to present with a mixed or (hypo)manic episode, and reported experiencing irritable and elevated mood more frequently. CONCLUSIONS: The results from the current study represent an important step in defining, and characterizing the longitudinal course of, empirically derived mood states that can be used to form the foundation of objective, empirical attempts to define meaningful subtypes of affective illness defined by clinical course.
BACKGROUND: Although bipolar disorder (BD) is a fundamentally cyclical illness, a divided model of BD that emphasizes polarity over cyclicity has dominated modern psychiatric diagnostic systems since their advent in the 1980s. However, there has been a gradual return to conceptualizations of BD which focus on longitudinal course in the research community due to emerging supportive data. Advances in longitudinal statistical methods promise to further progress the field. METHODS: The current study employed hidden Markov modeling to uncover empirically derived manic and depressive states from longitudinal data [i.e. Young Mania Rating Scale and Montgomery-Asberg Depression Rating Scale responses across five occasions from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) study], estimate participants' probabilities of transitioning between these states over time (n = 3918), and evaluate whether clinical variables (e.g. rapid cycling and substance dependence) predict participants' state transitions (n = 3229). RESULTS: Analyses identified three empirically derived mood states ('euthymic,' 'depressed,' and 'mixed'). Relative to the euthymic and depressed states, the mixed state was less commonly experienced, more temporally unstable, and uniquely associated with rapid cycling, substance use, and psychosis. Individuals assigned to the mixed state at baseline were relatively less likely to be diagnosed with BD-II (v. BD-I), more likely to present with a mixed or (hypo)manic episode, and reported experiencing irritable and elevated mood more frequently. CONCLUSIONS: The results from the current study represent an important step in defining, and characterizing the longitudinal course of, empirically derived mood states that can be used to form the foundation of objective, empirical attempts to define meaningful subtypes of affective illness defined by clinical course.
Authors: K D Denicoff; G S Leverich; W A Nolen; A J Rush; S L McElroy; P E Keck; T Suppes; L L Altshuler; R Kupka; M A Frye; J Hatef; M A Brotman; R M Post Journal: Psychol Med Date: 2000-11 Impact factor: 7.723
Authors: Jules Angst; Jean-Michel Azorin; Charles L Bowden; Giulio Perugi; Eduard Vieta; Alex Gamma; Allan H Young Journal: Arch Gen Psychiatry Date: 2011-08
Authors: Roy H Perlis; Michael J Ostacher; Joseph F Goldberg; David J Miklowitz; Edward Friedman; Joseph Calabrese; Michael E Thase; Gary S Sachs Journal: Neuropsychopharmacology Date: 2010-09-08 Impact factor: 7.853
Authors: Roy H Perlis; Sachiko Miyahara; Lauren B Marangell; Stephen R Wisniewski; Michael Ostacher; Melissa P DelBello; Charles L Bowden; Gary S Sachs; Andrew A Nierenberg Journal: Biol Psychiatry Date: 2004-05-01 Impact factor: 13.382
Authors: Joseph F Goldberg; Roy H Perlis; Charles L Bowden; Michael E Thase; David J Miklowitz; Lauren B Marangell; Joseph R Calabrese; Andrew A Nierenberg; Gary S Sachs Journal: Am J Psychiatry Date: 2009-01-02 Impact factor: 18.112
Authors: Christopher D Schneck; David J Miklowitz; Sachiko Miyahara; Mako Araga; Stephen Wisniewski; Laszlo Gyulai; Michael H Allen; Michael E Thase; Gary S Sachs Journal: Am J Psychiatry Date: 2008-01-15 Impact factor: 18.112